| |
|
|
|
|
|
|
|||
|
Blood, 15 February 2008, Vol. 111, No. 4, pp. 2062-2072. Prepublished online as a Blood First Edition Paper on November 14, 2007; DOI 10.1182/blood-2007-05-091207.
Submitted May 18, 2007
Center for Neurovirology & Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, United States * Corresponding author; email: gkanmogne{at}unmc.edu.
The relationship between neuroinflammation, blood-brain barrier (BBB) dysfunction, and progressive HIV-1 infection as they affect the onset and development of neuroAIDS is incompletely understood. One possible link is signal transducers and activators of transcription (STAT) pathways. These respond to pro-inflammatory and regulatory factors and could affect neuroinflammatory responses induced from infected cells and disease affected brain tissue. Our previous works demonstrated that HIV-1 activate pro-inflammatory and interferon-alpha-inducible genes in human brain microvascular endothelial cells (HBMEC) and that these genes are linked to the janus kinase (JAK)/STAT pathway. We now demonstrate that HIV-1 activates STAT1, induces IL-6 expression, and diminishes expression of claudin-5, ZO-1, and ZO-2 in HBMEC. The STAT1 inhibitor, fludarabine, blocked HIV-1-induced IL-6, diminished HIV-1-induced claudin-5 and ZO-1 downregulation, and blocked HIV-1- and IL-6-induced monocyte migration across a BBB model. Enhanced expression and activation of STAT1 and decreased claudin-5 was observed in microvessels from autopsy brains of patients with HIV-1-associated dementia. These data support the notion that STAT1 plays an integral role in HIV-1-induced BBB damage and is relevant to viral neuropathogenesis. Inhibition of STAT1 activation could provide a unique therapeutic strategy to attenuate HIV-1-induced BBB compromise and as such improve clinical outcomes.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||